Smooth Muscle Relaxation: Like in the case of ED, Vidalista works by inhibiting the enzyme phosphodiesterase type 5 (PDE5). This inhibition leads to increased levels of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the prostate and bladder. Increased cGMP levels result in smooth muscle relaxation, which can help alleviate symptoms associated with BPH.

Improved Urinary Flow: By relaxing the smooth muscle cells in the prostate and bladder, Vidalista may help improve urinary flow and reduce symptoms such as weak urine stream, difficulty initiating urination, and incomplete emptying of the bladder.

Reduced Frequency and Urgency: Vidalista may also help reduce the frequency and urgency of urination, particularly during the nighttime (nocturia). By relaxing the smooth muscle cells in the bladder, it can decrease the sensation of urgency and the need to urinate frequently.

Combination Therapy: In some cases, Vidalista may be used in combination with Cenforce medications commonly prescribed for BPH, such as alpha-blockers or 5-alpha reductase inhibitors. This combination therapy can provide additional benefits and better control of urinary symptoms in men with BPH.